Havens J, Kosakovsky Pond S, Zehr J, Pekar J, Parker E, Worobey M
bioRxiv. 2025; .
PMID: 40060453
PMC: 11888428.
DOI: 10.1101/2025.02.26.640439.
Gallo A, Sammartino J, Vazzana R, Giambruno R, Carcione C, Cuscino N
J Transl Med. 2025; 23(1):151.
PMID: 39905461
PMC: 11796281.
DOI: 10.1186/s12967-025-06158-2.
Lytras S, Lamb K, Ito J, Grove J, Yuan K, Sato K
J Virol. 2025; 99(2):e0160124.
PMID: 39878472
PMC: 11852828.
DOI: 10.1128/jvi.01601-24.
Wang Y, Xia B, Gao Z
J Virol. 2025; 99(2):e0204924.
PMID: 39878471
PMC: 11852741.
DOI: 10.1128/jvi.02049-24.
Souza U, Spilki F, Tanuri A, Roehe P, Campos F
Viruses. 2025; 17(1).
PMID: 39861853
PMC: 11768930.
DOI: 10.3390/v17010064.
Relation Between COVID-19 Infection and Vaccine and Menstrual Cycle Changes of Portuguese Adolescents in Higher Education.
Anastacio Z, Fernandes S, Alves R, Antao C, Carvalho P, Ferreira S
Healthcare (Basel). 2025; 13(1.
PMID: 39791609
PMC: 11719995.
DOI: 10.3390/healthcare13010002.
SARS-CoV-2 Omicron variations reveal mechanisms controlling cell entry dynamics and antibody neutralization.
Qing E, Salgado J, Wilcox A, Gallagher T
PLoS Pathog. 2024; 20(12):e1012757.
PMID: 39621785
PMC: 11637440.
DOI: 10.1371/journal.ppat.1012757.
Safety, tolerability, and efficacy of intranasally-administered detoxified LTh(αK) in mild-to-moderate COVID-19 patients: A randomized, double-blinded, placebo-controlled phase 2 study.
Cheng C, Su Y, Chen C, Chang M, Huang S, Huang P
Hum Vaccin Immunother. 2024; 20(1):2432105.
PMID: 39611611
PMC: 11610553.
DOI: 10.1080/21645515.2024.2432105.
How Trustworthy Are the Genomic Sequences of SARS-CoV-2 in GenBank?.
Xia X
Microorganisms. 2024; 12(11).
PMID: 39597576
PMC: 11596409.
DOI: 10.3390/microorganisms12112187.
SARS-CoV-2 and Environmental Changes: The Perfect Storm.
Caldarelli M, Rio P, Giambra V, Palucci I, Gasbarrini A, Gambassi G
Curr Issues Mol Biol. 2024; 46(11):11835-11852.
PMID: 39590297
PMC: 11592541.
DOI: 10.3390/cimb46110703.
Identification of compounds from natural Peruvian sources as potential inhibitors of SARS-CoV-2 Mpro mutations by virtual screening and computational simulations.
Barazorda-Ccahuana H, Carcamo Rodriguez E, Centeno-Lopez A, Paco-Chipana M, Goyzueta-Mamani L, Chavez-Fumagalli M
F1000Res. 2024; 13:246.
PMID: 39583212
PMC: 11585855.
DOI: 10.12688/f1000research.143633.3.
Virion morphology and on-virus spike protein structures of diverse SARS-CoV-2 variants.
Ke Z, Peacock T, Brown J, Sheppard C, Croll T, Kotecha A
EMBO J. 2024; 43(24):6469-6495.
PMID: 39543395
PMC: 11649927.
DOI: 10.1038/s44318-024-00303-1.
Current Updates on Variants of SARS-CoV- 2: Systematic Review.
Erkihun M, Ayele B, Asmare Z, Endalamaw K
Health Sci Rep. 2024; 7(11):e70166.
PMID: 39502131
PMC: 11534727.
DOI: 10.1002/hsr2.70166.
Molecular characterization, phylogenetic and variation analyses of SARS-CoV-2 strains in India.
Banerjee M, Chakraborty D, Chakraborty A
Virusdisease. 2024; 35(3):462-477.
PMID: 39464729
PMC: 11502728.
DOI: 10.1007/s13337-024-00878-7.
The evaluation of SARS-CoV-2 mutations at the early stage of the pandemic in Istanbul population.
Uyar Y, Mart Komurcu S, Artik Y, Cesur N, Tanriverdi A, Sanli K
Ann Clin Microbiol Antimicrob. 2024; 23(1):93.
PMID: 39390548
PMC: 11468081.
DOI: 10.1186/s12941-024-00750-y.
SARS-CoV-2 infection of domestic animals and their role in evolution and emergence of variants of concern.
Joseph O, Dahunsi S, Okoh A
New Microbes New Infect. 2024; 62:101468.
PMID: 39268173
PMC: 11391865.
DOI: 10.1016/j.nmni.2024.101468.
SARS-CoV-2 infectivity and antigenic evasion: spotlight on isolated Omicron sub-lineages.
Barrera A, Martinez-Valdebenito C, Angulo J, Palma C, Hormazabal J, Vial C
Front Med (Lausanne). 2024; 11:1414331.
PMID: 39267969
PMC: 11390582.
DOI: 10.3389/fmed.2024.1414331.
Evaluating the risk of SARS-CoV-2 reinfection with the Omicron or Delta variant in Wales, UK.
Postans M, Pacchiarini N, Song J, Cottrell S, Williams C, Beazer A
PLoS One. 2024; 19(9):e0309645.
PMID: 39240934
PMC: 11379141.
DOI: 10.1371/journal.pone.0309645.
Phylogenetic signatures reveal multilevel selection and fitness costs in SARS-CoV-2.
Bonetti Franceschi V, Volz E
Wellcome Open Res. 2024; 9:85.
PMID: 39132669
PMC: 11316176.
DOI: 10.12688/wellcomeopenres.20704.2.
A single-dose MCMV-based vaccine elicits long-lasting immune protection in mice against distinct SARS-CoV-2 variants.
Metzdorf K, Jacobsen H, Kim Y, Teixeira Alves L, Kulkarni U, Cokaric Brdovcak M
Front Immunol. 2024; 15:1383086.
PMID: 39119342
PMC: 11306140.
DOI: 10.3389/fimmu.2024.1383086.